CA9 and cancer: This result is in line with our previous finding that inhibition of CAIX catalytic activity with the CA inhibitor 6-Ethoxy-2-benzothiazolesulfonamide (EZA) does not inhibit CAIX-driven lactate transport in oocytes and cancer cells [18].